It remains therefore unknown whether AMACR deficiency can truly cause (recurrent) rhabdomyolysis or that these patients are more prone to a neuroleptic malignant syndrome due to neuroleptic medication. Here, AMACR is linked to neuroleptic malignant syndrome.